BOSTON SCIENTIFIC CORP Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Boston Scientific Corp quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Boston Scientific Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $1.57B.
  • Boston Scientific Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was $5M.
  • Boston Scientific Corp annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$548M, a 477% decline from 2021.
  • Boston Scientific Corp annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$95M, a 132% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5M +$553M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 -$548M -$453M -477% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 -$95M -$388M -132% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $293M -$2.68B -90.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $2.97B +$1.54B +108% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-23
2018 $1.43B +$1.32B +1202% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
2017 $110M +$316M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
2016 -$206M -$1.48B -116% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-19
2015 $1.28B +$1.43B Jan 1, 2015 Dec 31, 2015 10-K 2018-02-20
2014 -$150M +$474M +76% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-23
2013 -$624M +$140M +18.3% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-24
2012 -$764M +$964M +55.8% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-25
2011 -$1.73B -$1.22B -240% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-26
2010 -$508M Jan 1, 2010 Dec 31, 2010 8-K 2013-05-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.